Drug intelligence / Profile preview

Yang Xian Feng Dian Pill

Development stage: Unknown
Lead developer: Tianjin Pharmaceutical Da Ren Tang Group
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Yang Xian Feng Dian Pill (also known as Yangxian Fengdian Wan) is a traditional Chinese medicine (TCM) developed and manufactured by Jinsheng Da Ren Tang (specifically its Lerentang Pharmaceutical Factory). It is approved in China for the treatment of epilepsy, particularly for cases characterized by phlegm-heat internal blockage, sudden fainting, salivation, and limb twitching. The formulation is a complex herbal mixture containing 21 traditional Chinese medicinal ingredients, including processed Pinellia ternata (清半夏), ginger-processed Magnolia officinalis (厚朴), Bambusa textilis (天竺黄), Notopterygium incisum (羌活), Curcuma aromatica (郁金), Citrus reticulata (橘红), processed Arisaema erubescens (天南星), Gastrodia elata (天麻), vinegar-processed Cyperus rotundus (香附), vinegar-processed Corydalis yanhusuo (延胡索), Asarum sieboldii (细辛), bran-fried Citrus aurantium (枳壳), Aquilaria sinensis (沉香), vinegar-processed Curcuma zedoaria (莪术), Lindera aggregata (乌药), Saposhnikovia divaricata (防风), and Saiga tatarica horn (羚羊角). It functions by soothing the liver, regulating qi, resolving phlegm, and relieving convulsions.

Brand names: Yang Xian Feng Dian Pill
Other names: Yangxian Fengdian Wan羊痫疯癫丸

Beyond the preview

Go deeper on Yang Xian Feng Dian Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yang Xian Feng Dian Pill.

Explore the full profile